Thermo Fisher Scientific this week named Jim Manzi non-executive chairman of its board. He succeeds Paul Meister, who retired as chairman on April 10. Manzi was chairman of Thermo Electron from December 2003 through Nov. 9, 2006, when Thermo completed its merger with Fisher Scientific. He is currently chairman of Stonegate Capital. He was president, chairman, and CEO of Lotus Development from 1984 to 1995, when it was acquired by IBM.
Ciphergen this week appointed Steve Lundy senior vice president of sales and marketing, effective May 16. Lundy comes from GeneOhm, a division of BD Diagnostics, where he had been vice president of sales and marketing since 2003. He also has held various marketing positions at Esoterix and Bayer Diagnostics.